IncellDx IncellDx to Extend Precision Medicine Reach With Factorial Diagnostics Collaboration Premium IncellDx is also developing a suite of COVID-19 diagnostic products to answer long-term questions about the treatment of patients still suffering from the disease. IncellDx, Factorial Diagnostics Ink Licensing, Supply Agreement Factorial will use InCellDx's new IncellMax-Seq reagent to perform in situ library preparation for next-generation sequencing applications. In Brief This Week: Guardant Health, Illumina, Twist Bioscience, Hologic, InCellDx, More News items for the week of June 8, 2020. Biolidics, IncellDx Sign Distribution Agreement As part of the distribution agreement, Biolidics will distribute the IncellDx bioINK kit with Biolidics' ClearCell FX1 system. Beckman Coulter, IncellDx Form Cancer Assay Promotion Agreement The flow cytometry-based assays were developed by Menlo Park, California-based IncellDx to run on Beckman Coulter instrumentation. Aug 5, 2019 IncellDx Inks Chinese Collaboration, Distribution Agreements Dec 19, 2018 IncellDx, Zomedica to Develop Canine Cancer CTC Assay Aug 17, 2018 New Products Posted to GenomeWeb: Helomics, Empirical Bioscience, IncellDx, More May 21, 2018 IncellDx Gets CE Mark for HPV Assay May 10, 2018 IncellDx Signs Middle East, North Africa Distribution Deal With BPI Apr 10, 2018 CellMax Life, IncellDx Partner to Develop Circulating Tumor Cell Tests Jan 17, 2018 IncellDx Inks Dx Distribution Deal in India Jan 11, 2018 Celsee, IncellDx to Commercialize Assays After Cancer Study Collaboration Oct 19, 2017 IncellDx Inks Chinese Distribution Deal With GIMDx Feb 14, 2017 IncellDx, Celsee Diagnostics Partner on Cancer Immunotherapy Research Jan 6, 2017 IncellDx Gets IVD, CE-IVD Status for Single-Cell Prep Kit Jun 16, 2016 Melanoma Study Hints At Potential Benefits of Single-Cell Diagnostics on Tumor, Microenvironment Premium Nov 12, 2015 Beckman Coulter, IncellDx Ink Distribution Pact for HPV, Cancer Research in Asian Countries Apr 14, 2015 IncellDx Inks Exclusive Licensing Deal with Claremont BioSolutions Feb 27, 2014 People in the News: IncellDx Names Meda as CBO; Grossman Joins Telegraph Hill Partners Premium Feb 26, 2014 People in the News: Paul Grossman, Christine Meda Premium Oct 29, 2013 BMS, IncellDx Partner to Develop Molecular Test for Investigational Drug Jun 21, 2013 IncellDx, GeneCell Ink Pact to Offer HPV Test in India Jun 11, 2013 IncellDx, Kindstar Reach Deal to Bring HPV/Cervical Cancer Test to China Sep 12, 2012 IncellDx Partners with BRL on Trial of OncoTect 3Dx Load More Breaking News GA4GH Announces 10 New 'Driver' Projects, Including First Pediatric Partner Single-Cell MRD Assay Helps Characterize Cells Surviving Acute Myeloid Leukemia Therapy Research Triangle Institute Partners With GeneDx, Illumina for Expanded Newborn Screening Study Bionano Genomics' Third Chinese OEM Partner Gets NMPA Nod for Sample Prep Product InformedDNA Buys gWell Health, Names New CEO The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.